Group (I) | Group (II) | Group (III) | Test | p | ||||
Patient with first attack of bleeding (n = 35) | Patient with recurrent bleeding (n = 35) | Control patients (n = 29) | ||||||
No. | % | No. | % | No. | % | |||
Age (years) | ||||||||
Mean ± SD | 54 ± 9.6 | 53.7 ± 10.11 | 53.7 ± 9 | F, 0.008 | 0.99 | |||
Sex | ||||||||
Male | 23 | 65.7% | 19 | 54.3% | 17 | 58.6% | χ2, 0.965 | 0.78 |
Female | 12 | 34.3% | 16 | 45.7% | 12 | 41.4% | ||
HE | ||||||||
No | 29 | 82.9% | 25 | 71.4% | 25 | 86.2% | χ2, 5.25 | 0.26 |
Grade I | 3 | 8.6% | 2 | 5.7% | 0 | 0% | ||
Grade II | 3 | 8.6 | 8 | 22.9% | 4 | 13.8% | ||
Ascites | ||||||||
No | 10 | 28.6% | 4 | 11.4% | 14 | 48.3% | χ2, 17.13 | 0.0088 |
Minimal | 4 | 11.4% | 3 | 8.6% | 0 | 0% | ||
Moderate | 9 | 25.7% | 15 | 42.9% | 12 | 41.4% | ||
Severe | 12 | 34.3 5 | 13 | 37.1% | 3 | 10.3% | ||
Virology | ||||||||
Negative | 3 | 8.6% | 3 | 8.6% | 4 | 13.8% | χ2, 3.85 | 0.42 |
HBV | 2 | 5.7% | 7 | 20% | 4 | 13.8% | ||
HCV | 30 | 85.7% | 25 | 71.4% | 21 | 72.4% | ||
Group (I) Patient with first attack of bleeding (n = 35) | Group (II) Patient with recurrent bleeding (n = 35) | Group (III) Control patients (n = 29) | Test | p | ||||
WBC (×103/mm3), median (range) | 9.8 (3.3 – 12.8) | 9.0 (1.7 – 14.5) | 9.6 (4.3-12) | KW, 0.607 | 0.715 | |||
Hemoglobin (g/dl), mean ± SD | 8.54 ± 1.96 | 8.35 ± 1.58 | 10.56 ± 1.11 | F, 17.7 | < 0.001 | |||
Platelet (×103/mm3), mean ± SD | 110.11 ± 39.9 | 86.17 ± 31.55 | 115.2 ± 23.6 | F, 7.4 | 0.001 | |||
INR, median (range) | 1.39(1.02-2.45) | 1.65 (1.09-2.65) | 1.22 (1.04-2.17) | KW, 17.8 | < 0.0001 | |||
Creatinine (mg/dl), median (range) | 0.99 (0.45-1.6) | 0.98 (0.25-2.5) | 0.77 (0.46-4.3) | KW, 2.79 | 0.247 | |||
Urea (mg/dl), median (range) | 24 (11-66) | 27 (14–82) | 25 (13-32.2) | KW, 0.64 | 0.64 | |||
Albumin (g/dL), mean ± SD | 2.8 ± 0.44 | 2.66 ± 0.61 | 2.98 ± 0.46 | F, 2.91 | 0.05 | |||
Total bilirubin (mg/dl), median (range) | 1.26 (0.3-4.4) | 1.44 (0.59-35.3) | 1.19 (0.51-30.9) | KW, 1.22 | 0.5 | |||
Direct bilirubin (mg/dl), median (range) | 0.77 (0.11-2.99) | 0.78 (0.12-30.57) | 0.84 (0.16-20.8) | KW, 0.17 | 0.9 | |||
Spleen diameter (cm), median (range) | 12 (9-16) | 13.5 (10-16) | 10.5 (10-11) | KW, 9.86 | < 0.001 | |||
PV diameter (mm), mean ± SD | 13.76 ± 0.5 | 13.78 ± 0.47 | 13.74 ± 0.47 | F, 0.066 | 0.93 |